Investors Win Class Cert. Against Failed COVID Test Maker
By Emilie Ruscoe · February 12, 2024, 10:16 PM EST
Investors suing biotech company Talis Biomedical Corp. have received class certification in a suit alleging the company hurt investors when trading prices sank a month after its initial public offering when...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login